TranS1 Announces Commercial Launch of AxiaLIF System

TranS1, a medical device firm focused on developing minimally invasive product solutions for the treatment of lower back pain, has announced the U.S. market release of its Axial Lumbar Interbody Fusion (AxiaLIF) System.

The AxiaLIF System is the least invasive approach to lumbar fusion and, according to a recent clinical study, dramatically reduces patient recovery time in comparison to traditional lumbar fusion procedures. AxiaLIF employs a novel approach to accessing the lowest portion of the lumbar spine through a percutaneous opening via the sacral bone.

This minimally invasive access enables surgeons to perform lumbar fusion without the major dissections of the surrounding spinal soft tissue structures associated with conventional fusion surgery. In a recent clinical study, AxiaLIF patients were able to walk the same day of the surgery, most were released from the hospital within 24 hours and, on average, returned to work within 15 days.